MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

19.37 7.97

Resumen

Variación precio

24h

Actual

Mínimo

16

Máximo

19.6

Métricas clave

By Trading Economics

Ingresos

-681K

Ventas

17M

P/B

Media del Sector

48.528

87.826

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

-79M

-74M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+5.26% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

19M

387M

Apertura anterior

11.4

Cierre anterior

19.37

Noticias sobre sentimiento de mercado

By Acuity

30%

70%

94 / 370 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 ene 2026, 22:18 UTC

Charlas de Mercado

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 ene 2026, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 ene 2026, 21:43 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 ene 2026, 20:39 UTC

Charlas de Mercado

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 ene 2026, 20:38 UTC

Charlas de Mercado

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 ene 2026, 20:36 UTC

Adquisiciones, fusiones, absorciones

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 ene 2026, 20:30 UTC

Charlas de Mercado

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 ene 2026, 20:15 UTC

Charlas de Mercado

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 ene 2026, 20:07 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

9 ene 2026, 20:07 UTC

Charlas de Mercado

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 ene 2026, 19:58 UTC

Adquisiciones, fusiones, absorciones

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 ene 2026, 19:42 UTC

Charlas de Mercado

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 ene 2026, 19:38 UTC

Adquisiciones, fusiones, absorciones

Wolters Kluwer Acquires StandardFusion >WTKWY

9 ene 2026, 19:31 UTC

Ganancias

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 ene 2026, 19:28 UTC

Ganancias

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 ene 2026, 18:30 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 ene 2026, 18:23 UTC

Charlas de Mercado

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 ene 2026, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

9 ene 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

9 ene 2026, 17:19 UTC

Charlas de Mercado

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

9 ene 2026, 17:07 UTC

Charlas de Mercado

McDonald's Promotions Appear Successful -- Market Talk

9 ene 2026, 17:06 UTC

Charlas de Mercado

Oil Futures on Track for Weekly Gains -- Market Talk

9 ene 2026, 17:05 UTC

Ganancias

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9 ene 2026, 16:57 UTC

Charlas de Mercado

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9 ene 2026, 16:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

9 ene 2026, 16:46 UTC

Charlas de Mercado

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

5.26% repunte

Estimación a 12 Meses

Media 19 USD  5.26%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

94 / 370 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat